Literature DB >> 1454209

Inhibition of nitric oxide synthesis does not reduce infarct volume in a rat model of focal cerebral ischaemia.

D A Dawson1, K Kusumoto, D I Graham, J McCulloch, I M Macrae.   

Abstract

The effect of the nitric oxide (NO) synthesis inhibitor Ng-nitro-L-arginine methylester (L-NAME) on ischaemic brain damage was determined in a rat model of focal cerebral ischaemia. Ischaemia was induced by permanent occlusion of the left middle cerebral artery (MCA) and infarction assessed 4 h post-occlusion by quantitative histopathology. L-NAME (30 mg/kg s.c.), administered 30 min pre- and 30 min post-MCA occlusion, did not significantly alter the volume of ischaemic damage in the cerebral hemisphere, neocortex or caudate nucleus compared with saline controls. This result provides no support for the view that NO generation is a key component in the post-ischaemic cascade leading to acute neuronal death.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1454209     DOI: 10.1016/0304-3940(92)90361-a

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  10 in total

Review 1.  Trends and future developments in the pharmacological treatment of acute ischaemic stroke.

Authors:  G J del Zoppo; S Wagner; M Tagaya
Journal:  Drugs       Date:  1997-07       Impact factor: 9.546

Review 2.  Glutamate receptors, neurotoxicity and neurodegeneration.

Authors:  Anthony Lau; Michael Tymianski
Journal:  Pflugers Arch       Date:  2010-03-14       Impact factor: 3.657

3.  Nitric oxide synthetase activity in cerebral post-ischemic reperfusion and effects of L-N(G)-nitroarginine and 7-nitroindazole on the survival.

Authors:  V Sorrenti; C Di Giacomo; A Campisi; J R Perez-Polo; A Vanella
Journal:  Neurochem Res       Date:  1999-07       Impact factor: 3.996

4.  Publication bias in reports of animal stroke studies leads to major overstatement of efficacy.

Authors:  Emily S Sena; H Bart van der Worp; Philip M W Bath; David W Howells; Malcolm R Macleod
Journal:  PLoS Biol       Date:  2010-03-30       Impact factor: 8.029

5.  Characterization of the novel nitric oxide synthase inhibitor 7-nitro indazole and related indazoles: antinociceptive and cardiovascular effects.

Authors:  P K Moore; P Wallace; Z Gaffen; S L Hart; R C Babbedge
Journal:  Br J Pharmacol       Date:  1993-09       Impact factor: 8.739

6.  Attenuated neurotransmitter release and spreading depression-like depolarizations after focal ischemia in mutant mice with disrupted type I nitric oxide synthase gene.

Authors:  M Shimizu-Sasamata; P Bosque-Hamilton; P L Huang; M A Moskowitz; E H Lo
Journal:  J Neurosci       Date:  1998-11-15       Impact factor: 6.167

7.  Blockade of tetrahydrobiopterin synthesis protects neurons after transient forebrain ischemia in rat: a novel role for the cofactor.

Authors:  S Cho; B T Volpe; Y Bae; O Hwang; H J Choi; J Gal; L C Park; C K Chu; J Du; T H Joh
Journal:  J Neurosci       Date:  1999-02-01       Impact factor: 6.167

8.  Reduction by NG-nitro-L-arginine of H2O2-induced endothelial cell injury.

Authors:  S Shimizu; M Nomoto; T Yamamoto; K Momose
Journal:  Br J Pharmacol       Date:  1994-10       Impact factor: 8.739

9.  Anti-ischaemic efficacy of a nitric oxide synthase inhibitor and a N-methyl-D-aspartate receptor antagonist in models of transient and permanent focal cerebral ischaemia.

Authors:  D A Dawson; D I Graham; J McCulloch; I M Macrae
Journal:  Br J Pharmacol       Date:  1994-09       Impact factor: 8.739

Review 10.  Expression of nitric oxide synthase-2 in glia associated with CNS pathology.

Authors:  A K Loihl; S Murphy
Journal:  Prog Brain Res       Date:  1998       Impact factor: 2.453

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.